Healthcare
M&A Advisory
Food
Pharmaceutical
M&A Advisory
Lazard
Full Credential Description
Aimmune Therapeutics. Switzerland, United States. Announced Date 30/08/2020. Closed Date 14/10/2020. Deal value: $2600m. Aimmune Therapeutics to be acquired by Sociétés des Produits Nestlé S.A., part of Nestlé Health Science. Industry: Aimmune Therapeutics is a biopharmaceutical company focused on developing treatments for food allergies.